Targeting LncRNA <i>ADAMTS9-AS1</i> is a Promising Therapeutic Strategy to Inhibit the Progression of Bladder Cancer

For Authors|For Editors|For Reviewers

Targeting LncRNA ADAMTS9-AS1 is a Promising Therapeutic Strategy to Inhibit the Progression of Bladder Cancer

Zhu Yu, Gongxiang Tan, Chunyan Yu, Yamei Chen, Huijie Zheng, Wenfang Xu, Mingzhu Yu

Discovery Medicine . 2024, (191): 2454 -2464 . DOI: 10.24976/Discov.Med.202436191.226

About Discovery Medicine
Editorial Board
Article Processing Charge
Submit

For Authors
For Editors
For Reviewers

Open Access Statement
Copyright & License
Digital Archive

Latest Issue
All Issues
Special Issues

By using this website, you agree to our Terms & Conditions and Privacy Policy.

Disclaimer

The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and insitutional affiliations.